Patent · US Active

Method and assay for determining FAS expression

US8685891B2 · kind B2 · utility

32Cited by
6References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 26, 2010
Grant dateApr 1, 2014
Priority date
Expiry dateSep 28, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and immunoassays for the determination of fatty acid synthase (FAS) expression in patients having or suspected of having a proliferative disorder, especially prostate cancer, are disclosed. The sensitive method and assay detect the level of expression of FAS in a biological sample using antibodies that are highly specific for FAS. The method and assay can be used to monitor the progression of cancer, and/or to predict the efficacy of certain treatments or the likelihood of recurrence of the cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.